Filter
1076
Text search:
advisory
Featured
Recommendations
91
New Publications
255
Language
Document type
No document type
507
Studies & Reports
197
Guidelines
185
Strategic & Response Plan
73
Manuals
60
Fact sheets
23
Situation Updates
14
Training Material
8
Resource Platforms
5
Brochures
1
Dashboards/Maps
1
App
1
Infographics
1
Countries / Regions
Global
44
India
43
South Africa
26
Nepal
20
Kenya
20
Ethiopia
19
Malawi
19
Nigeria
17
Brazil
17
Latin America and the Carribbean
16
Uganda
15
Ghana
13
Rwanda
13
Africa
13
Western and Central Europe
12
Congo, Democratic Republic of
11
Sierra Leone
10
Zambia
10
Namibia
10
Myanmar / Burma
10
Liberia
9
Syria
9
Ukraine
9
Guinea
8
South Sudan
8
Bangladesh
8
Asia
8
Philippines
7
West and Central Africa
7
South–East Asia Region
7
Zimbabwe
6
Mozambique
6
Benin
6
Afghanistan
5
Germany
5
Russia
5
Pakistan
4
Tanzania
4
Colombia
4
Botswana
4
East and Southern Africa
4
Venezuela
4
Senegal
3
USA
3
Chile
3
Yemen
3
Eastern Europe
3
Côte d’Ivoire / Ivory Coast
2
Cameroon
2
Lebanon
2
Chad
2
Cambodia
2
Thailand
2
Papua New Guinea
2
Sudan
2
Argentina
2
Eswatini/ Swaziland
2
Hungary
2
Angola
2
Middle East and North Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Moldova
2
Georgia
2
United Kingdom
2
Burkina Faso
1
Guinea-Bissau
1
Morocco
1
Niger
1
Togo
1
Haiti
1
Somalia
1
Iraq
1
Jordan
1
Turkey
1
Indonesia
1
Singapore
1
Central African Republic
1
Peru
1
North Macedonia
1
Ecuador
1
Mexico
1
Sri Lanka
1
Paraguay
1
Fiji
1
Bhutan
1
Poland
1
Albania
1
Southern Africa
1
Tajikistan
1
Estonia
1
Romania
1
Uzbekistan
1
Kyrgyzstan
1
Jamaica
1
Denmark
1
Maldives
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
333
Clinical Guidelines
96
Women & Child Health
63
Public Health
62
Key Resources
61
Pharmacy & Technologies
17
Capacity Building
11
Annual Report MEDBOX
1
Toolboxes
COVID-19
133
TB
65
Mental Health
64
HIV
63
AMR
48
Planetary Health
48
NTDs
45
Disability
39
Caregiver
31
Rapid Response
28
Ebola & Marburg
27
Conflict
24
Pharmacy
24
Global Health Education
22
Refugee
21
NCDs
20
Polio
18
2.0 Rapid Response
15
Natural Hazards
11
Zika
11
Malaria
11
Health Financing Toolbox
10
Specific Hazards
9
Cholera
3
Social Ethics
3
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the back
...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professional
...
This Strategic Operating Framework (SOF) has been developed to guide WASH Sector partners in responding to humanitarian needs in Sudan in conjunction with the existing and forthcoming humanitarian response plans (2022 and 2023). This SOF is drafted in consultation with the Strategic
...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary include
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the b
...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical
...
Discussion paper initially prepared in April 2015 to facilitate feedback, and finalized after the
June 2015 meeting of WHO’s Strategic and Technical Advisory Group for TB (STAG-TB).
How to recognise Post-Traumatic Stress Disorder | The nature and cause of Post-Traumatic Stress Disorder | Treatment and referral | Sources of further information | Compiled by the Scientific & Advisory Board Members of the South African Depression
...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immu
...
Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory
...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm
...
The goal of the global outbreak response for monkeypox is to stop human-to-human transmission of monkeypox, with a priority focus on communities at high risk of exposure which may differ according to context, and to effectively use strong public health measures to prevent onward spread of the diseas
...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El
...
This annual report presents key highlights of our results and are a testament to our staff’s hard work and dedication to safeguarding Africa’s health. We are indebted to the continued support of the Chairperson of the African Union Commission, the Africa CDC Governing Board, and the Technical an
...
The new WHO recommendations for rabies immunization supersede the 2010 WHO position
on pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for rabies. These updated
recommendations are based on new evidence and directed by public health needs that are cost-,
dose- and time-sparing
...
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines
...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associated with current serological tests makes it difficu
...
The risk of emergence and re-emergence of arboviruses with pandemic potential has increased as a global public health threat and will continue to do so in the years to come. The Global Arbovirus Initiative outlines an integrated approach across these viruses and disciplines that will enable optimal
...
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
